Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group


Click on country-registry for comparison

FlagCountry-registryRegistration periodNo. of casesMaleFemaleNumber of cases by age groupRelative survival by age group
5-year survival5-year survival
No.AbsRelNo.AbsRel<4545-5455-6465-7475+<4545-5455-6465-7475+
China - Shangai 1992-1995545448.157.73192021101.00.071.065.640.4
China - Tianjin 1991-1999575761.271.34719121576.065.871.384.261.8
Singapore 1993-1997353554.362.0377612100.643.760.077.758.3
Republic of Korea - Busan 1996-2001252562.167.25558278.2101.562.358.40.0
Republic of Korea - Seoul 1993-1997555560.066.41081119760.463.584.759.168.0
Thailand - Chiang Mai 1993-1997282836.439.42561050.072.363.30.075.2
Thailand - Lampang 1990-2000303058.862.08458575.567.662.050.847.9



Graphs:


Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period